97 related articles for article (PubMed ID: 2931019)
61. Cardiovascular complications of intravenous vasopressin therapy.
Jacoby AG; Wiegman MV
Focus Crit Care; 1990 Feb; 17(1):63-6. PubMed ID: 2311776
[No Abstract] [Full Text] [Related]
62. Gangrene of the feet associated with mesenteric intraarterial vasopressin.
Twiford TW; Granmayeh M; Tucker MJ
AJR Am J Roentgenol; 1978 Mar; 130(3):558-60. PubMed ID: 415570
[No Abstract] [Full Text] [Related]
63. Angiographic methods for the control of gastric hemorrhage.
Athanasoulis CA
Am J Dig Dis; 1976 Feb; 21(2):174-81. PubMed ID: 775972
[No Abstract] [Full Text] [Related]
64. Cutaneous changes produced by prolonged systemic steroid therapy.
Leigh IM; Sanderson KV
Br J Dermatol; 1979 Jul; 101 Suppl 17():71-3. PubMed ID: 157156
[No Abstract] [Full Text] [Related]
65. Vasopressin infusion vs surgery for GI hemorrhage in a patient with recent myocardial infarction.
Newman K; Numaguchi Y; Holmes JW
South Med J; 1987 Jun; 80(6):797. PubMed ID: 3495888
[No Abstract] [Full Text] [Related]
66. Cutaneous calcinosis--an unusual complication of intravenous phosphate administration.
Mills CM; Knight AG
Clin Exp Dermatol; 1993 Jul; 18(4):370-2. PubMed ID: 8403480
[TBL] [Abstract][Full Text] [Related]
67. Clues: bruised, torn skin.
Cuzzell JZ
Am J Nurs; 1990 Mar; 90(3):16, 18. PubMed ID: 2309800
[No Abstract] [Full Text] [Related]
68. Vasopressin-associated cutaneous infarcts, alopecia, and neuropathy.
Maceyko RF; Vidimos AT; Steck WD
J Am Acad Dermatol; 1994 Jul; 31(1):111-3. PubMed ID: 8021352
[No Abstract] [Full Text] [Related]
69. A rare complication of cough.
Tseng CK; Tseng YC; Chen WK; Lee FY
Intern Med; 2007; 46(15):1269-70. PubMed ID: 17675785
[No Abstract] [Full Text] [Related]
70. Correction: vasopressin infusions in bleeding varices.
Adler RD
West J Med; 1982 Jun; 136(6):539. PubMed ID: 18749137
[No Abstract] [Full Text] [Related]
71. Management of vasodilatory shock: defining the role of arginine vasopressin.
Dunser MW; Wenzel V; Mayr AJ; Hasibeder WR
Drugs; 2003; 63(3):237-56. PubMed ID: 12534330
[TBL] [Abstract][Full Text] [Related]
72. Portal vein thrombosis following combined endoscopic variceal sclerosis and vasopressin therapy for bleeding varices.
Stoltenberg PH; Goodale RL; Silvis SE
Am J Gastroenterol; 1987 Dec; 82(12):1297-300. PubMed ID: 3500637
[TBL] [Abstract][Full Text] [Related]
73. Esophageal varices.
Goff JS
Gastrointest Endosc Clin N Am; 1994 Oct; 4(4):747-71. PubMed ID: 7812645
[TBL] [Abstract][Full Text] [Related]
74. Up-dated surgical strategies in portal hypertension.
Mühe E
Hepatogastroenterology; 1981 Apr; 28(2):125-7. PubMed ID: 7011931
[No Abstract] [Full Text] [Related]
75. Cutaneous manifestations of intravenous vasopressin therapy.
Thomas TK
Am J Gastroenterol; 1985 Sep; 80(9):704-5. PubMed ID: 2931019
[TBL] [Abstract][Full Text] [Related]
76. Local gangrene: a complication of peripheral Pitressin therapy for bleeding esophageal varices.
Greenwald RA; Rheingold OJ; Chiprut RO; Rogers AI
Gastroenterology; 1978 Apr; 74(4):744-6. PubMed ID: 305380
[TBL] [Abstract][Full Text] [Related]
77. Cutaneous reaction to vasopressin.
Lemlich G; Di Grandi S; Szaniawski WK
Cutis; 1996 May; 57(5):330-2. PubMed ID: 8726714
[TBL] [Abstract][Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
